Production of isoprenoids
View Patent ↗Methods for producing an isoprenoid are provided. A plurality of bacterial or fungal host cells is obtained. These cells comprise a heterologous nucleic acid encoding one or more enzymes of a mevalonate pathway for making isopentenyl pyrophosphate. Expression of the one or more enzymes is under control one or more heterologous transcriptional regulator. The mevalonate pathway comprises (i) an enzyme that condenses acetoacetyl-CoA with acetyl-CoA to form HMG-CoA, (ii) an enzyme that converts HMG-CoA to mevalonate, (iii) an enzyme that phosphorylates mevalonate to mevalonate 5-phosphate, (iv) an enzyme that converts mevalonate 5-phosphate to mevalonate 5-pyrophosphate, and (v) an enzyme that converts mevalonate 5-pyrophosphate to isopentenyl pyrophosphate. The host cells are cultured in a medium under conditions that are suboptimal as compared to conditions for the maximum growth rate. Temperature is maintained at a level below that which would provide for a maximum specific growth rate for the host cells.
1. A method for producing an isoprenoid comprising:
(a) obtaining a plurality of bacterial, fungal or yeast host cells that comprise a mevalonate or deoxyxylulose 5-phosphate (DXP) pathway for making isopentenyl pyrophosphate and wherein one or more of the pathway enzymes are under control of at least one heterologous transcriptional regulator; and
(b) culturing the host cells in a medium under conditions that are suboptimal as compared to conditions that would provide for a maximum specific growth rate for the host cells,
wherein the suboptimal conditions comprise culturing in a medium that has a carbon source, a temperature, a nitrogen source, or any combination thereof, which are below that which would provide for the maximum specific growth rate for the host cells, and
wherein culturing the host cells in the medium under the suboptimal conditions leads to increased production of the isoprenoid compared to culturing the host cells under conditions that would provide for the maximum specific growth rate for the host cells.
2. The method of claim 1 , wherein the pathway is the mevalonate pathway.
3. The method of claim 1 , wherein the pathway is the DXP pathway.
4. The method of claim 1 , wherein the at least one heterologous transcriptional regulator is inducible.
5. The method of claim 1 , wherein the pathway enzymes are under control of a single transcriptional regulator.
6. The method of claim 1 , wherein the pathway enzymes are under control of a multiple transcriptional regulator.
7. The method of claim 1 , wherein the host cells are Escherichia coli.
8. The method of claim 1 , wherein the host cells are fungi.
9. The method of claim 1 , wherein the host cells are Saccharomyces cerevisiae.
10. The method of claim 2 , wherein the pathway comprises a nucleic acid sequence encoding a mevalonate pathway enzyme from a bacteria having an endogenous mevalonate pathway.
11. The method of claim 10 , wherein the bacteria is of a genus selected from the group consisting of Enterococcus, Pseudomonas , and Staphylococcus.
12. The method of claim 11 , wherein the nucleic acid sequence encodes a mevalonate pathway enzyme selected from the group consisting of acetyl-CoA thiolase, HMG-CoA synthase, HMG-CoA reductase, and mevalonate kinase.
13. The method of claim 10 , wherein the nucleic acid sequence encodes a Class II HMG reductase.
14. The method of claim 1 , wherein the host cells are cultured in the medium wherein nutrient or temperature or both are maintained at a level below that which would provide for the maximum specific growth rate for the host cells.
15. The method of claim 1 , wherein the temperature of the medium is at least about 2-20° C. below that which would provide for the maximum specific growth rate.
16. The method of claim 15 , wherein the host cells are cultured at a temperature at least 5° C. below that which would provide for the maximum specific growth rate.
17. The method of claim 15 , wherein the temperature of the medium is at least 10° C. below that which would provide for the maximum specific growth rate.
18. The method of claim 1 , wherein the medium comprises a carbon source and the amount of carbon source will provide for about 90% or less of the maximum specific growth rate.
19. The method of claim 18 , wherein the amount of the carbon source will provide for about 75% or less of the maximum specific growth rate.
20. The method of claim 18 , wherein the amount of the carbon source will provide for about 50% or less of the maximum specific growth rate.
21. The method of claim 18 , wherein the amount of the carbon source will provide for about 25% or less of the maximum specific growth rate.
22. The method of claim 18 , wherein the amount of the carbon source will provide for about 75%-10% of the maximum specific growth rate.
23. The method of claim 1 , wherein the medium comprises a nitrogen source present in an amount below that which would provide for about 90% or less of the maximum specific rate.
24. The method of claim 23 , wherein the amount of the nitrogen source will provide for about 75% or less of the maximum specific growth rate.
25. The method of claim 23 , wherein the amount of the nitrogen source will provide for 50% or less of the maximum specific growth rate.
26. The method of claim 23 , wherein the amount of the nitrogen source will provide for about 25% or less of the maximum specific growth rate.
27. The method of claim 23 , wherein the amount of the nitrogen source will provide for about 75%-10% of the maximum specific growth rate.
28. The method of claim 1 , wherein the isoprenoid is produced in an amount greater than about 10 grams per liter of medium.
29. The method of claim 1 , wherein the isoprenoid is produced in an amount greater than about 50 mg per gram of dry cell weight.
30. The method of any one of claim 28 or 29 wherein the amount of isoprenoid is produced in less than about 150 hours.
31. The method of any one of claim 28 or 29 , wherein the amount of isoprenoid is produced in less than about 96 hours.
32. The method of any one of claim 28 or 29 wherein the amount of isoprenoid is produced in less than about 72 hours.
33. The method of claim 1 , wherein the host cells are cultured at a temperature below that which would provide for the maximum specific growth rate, and wherein the host cells are cultured in the medium in which carbon source is maintained at a level below that which would provide for the maximum specific growth rate.
34. The method of claim 1 , wherein the isoprenoid is selected from the group consisting of a hemiterpene, monoterpene, diterpene, triterpene, tetraterpene, and polyterpene.
35. The method of claim 1 , wherein the isoprenoid is not a carotenoid.
36. The method of claim 1 , wherein the isoprenoid is a C 5 -C 20 isoprenoid.
37. The method of claim 1 , wherein the isoprenoid is selected from the group consisting of abietadiene, amorphadiene, carene, α-farnesene, β-farnesene, farnesol, geraniol, geranylgeraniol, isoprene, linalool, limonene, myrcene, nerolidol, ocimene, patchoulol, β-pinene, sabinene, γ-terpinene, terpinolene and valencene.